IU eyes clinical trials to boost research success
The new head of research at the Indiana University School of Medicine thinks the institution is missing out on the more than $6 billion spent each year in the United States on clinical trials.
Health Care
Articles
Feds detail why they want Armstrong medical records
The federal government says it wants Lance Armstrong's medical records from his 1996 cancer treatments because they could prove just how far he was willing to go to conceal performance-enhancing drug use from the public and his sponsors.
Indianapolis doctor charged in overdose deaths of 3 patients
Dr. John Sturman overprescribed narcotics to patients at a clinic he operated at Indiana University Hospital, Marion County prosecutors contend. The deaths occurred in 2010 and 2011.
UPDATE: IU Health reaches labor settlement with nurses
Indiana University Health has agreed to revoke disciplinary actions against two nurses who tried to organize a union at IU Health’s Methodist Hospital earlier this year, the United Steelworkers announced.
Financial planning especially tricky for those with special-needs children
Many parents of children with special needs have to choose between working to help cover added expenses or unemployment so they can tend to their child full time. Financial planning is vital for these families, parents and special-needs advocates said.
UPDATE: Feds demand Armstrong medical records from IU
The government wants to see Lance Armstrong’s medical records from his treatments for cancer as it attempts to recover millions of dollars in sponsorship money paid to his cycling teams.
Lilly accused at trial of hiding Cymbalta ‘brain zap’ risk
The drugmaker faces as many as 5,000 cases claiming it downplayed Cymbalta’s withdrawal risks, which allegedly include electrical-shock sensations, vomiting and insomnia.
Indiana medical software company hack affected 3.9M people
The company said the exposed information includes names, addresses, birthdates, Social Security numbers and health records.
Tech firm to sponsor free rides for downtown bikeshare
Pedestrians in downtown Indy this weekend can become bicyclists for no charge, as a global technology firm sponsors free rides through the Indiana Pacers Bikeshare program.
Health spending to gobble up more of U.S. economy
Payments for hospitals, doctors, drugs and insurance will rise by about 5.8 percent a year through 2024—1.1 percentage points faster than overall economic growth, actuaries at the Centers for Medicare and Medicaid Services said Tuesday in an annual study.
Anthem gets $26.5B funding commitment for Cigna takeover
Anthem Inc.’s bid to become the largest health insurer in history is setting up one of the biggest debt offerings backing a takeover.
Health insurer deal fever may spread to hospitals next
Seeing mergers like Anthem’s planned acquisition of Cigna Corp., hospitals could decide that striking deals of their own could improve their negotiating power over medical reimbursements.
City dodges bullet as HQ stays under Anthem-Cigna deal
The company says its corporate headquarters will remain in Indianapolis, where its operations are responsible for contributing millions of dollars in corporate taxes and charitable giving.
VA secretary optimistic Congress will plug budget gap
During a visit to the Richard L. Roudebush VA Medical Center in Indianapolis, Robert McDonald said Thursday he thinks Congress will act to avoid shutting down some VA hospitals and other cost-cutting steps.
Anthem to buy Cigna in $54B deal
After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.
Anthem’s next challenge: getting regulators to say OK
The next challenge for Anthem Inc. in its quest to marry Cigna Corp. is to get its legal guardians to allow the ceremony to happen.
Indy’s top 11 acquisition deals, before Anthem-Cigna
Anthem’s $54 billion bid for rival insurer Cigna is twice the size of the next-largest acquisition in the Indianapolis area, which occurred nearly a decade ago.
Lilly posts lackluster profit but boosts full-year forecast
Eli Lilly and Co.’s profits plunged 18 percent in the second-quarter but still easily beat the lowered expectations of Wall Street analysts.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Study shows Lilly’s Alzheimer’s drug has small but lasting benefit
New data released Wednesday morning suggest that Eli Lilly and Co.’s Alzheimer’s drug has a modest but lasting impact on the memory-sapping disease. But analysts worry the impact is too small to be meaningful.